GeneProt Inc.
www.geneprot.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From GeneProt Inc.
Cellzome GMBH
Cellzome is the first biotechnology company founded on the EMBL campus in Heidelberg. With proprietary proteomics platforms developed at the EMBL, Cellzome will apply its technology on a large scale for target discovery, validation and drug development.
Start-Up Previews (7/01)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups focus on Biorepositories (Asterand Inc., BioSample Inc., Genomics Collaborative Inc., TissueInformatics Inc.); Therapeutics for Diabetes and Obesity (Arexis AB, Diabetogen Biosciences Inc., PanCel Corp., Rademacher Group Ltd.); and Orthopedic and Surgical Devices (Ascension Orthopedics Inc., Coapt Systems Inc., NuVasive Inc., SpringFlex Orthopedics Inc.). Plus these Selected Start-Ups across Health Care: Achillion Pharmaceuticals Inc., GeneProt Inc., MonitorForHire.com and Targacept Inc.
GeneProt Inc.
Boasting an impressive group of scientific founders, 17-month-old GeneProt Inc. has raised $122 million from a variety of institutional and corporate sources. With that money, it has built what the company touts as the first large-scale proteomics discovery and production facility. It hopes to leverage that firepower into a variety of revenue sources including the sale of novel therapeutics to pharmaceutical company sponsors.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
- Synthesis Technologies, Production Processes
-
Drug Discovery Tools
- Bioinformatics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice